Metraipolis › archive › dc_7421decbe7bd

Emerging synthetic biology-assisted technologies for overcoming antibiotic resistance: CRISPR-Cas, bacteriophage, microbiome, and metabolic engineering-based… — Europe PMC PMID:41923586

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41923586
DOI
10.71150/jm.2512002
License (as archived)
solo-consultazione
Archived
2026-11-03T15:45:34.841Z
SHA-256 of the archived text
ffd01d83ebcbcb8afd2bbf8a88144c279ab39df6b5b407266ffdb5cbd85ff462
Stable URL of this page
https://metraipolis.com/documento/dc_7421decbe7bd

How to cite

Emerging synthetic biology-assisted technologies for overcoming antibiotic resistance: CRISPR-Cas, bacteriophage, microbiome, and metabolic engineering-based… — Europe PMC PMID:41923586 — Europe PMC (en), https://europepmc.org/article/MED/41923586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7421decbe7bd (Metraipolis archive dc_7421decbe7bd, sha256 ffd01d83ebcbcb8afd2bbf8a88144c279ab39df6b5b407266ffdb5cbd85ff462)
BibTeX
@misc{dc7421decbe7bd,
  title = {Emerging synthetic biology-assisted technologies for overcoming antibiotic resistance: CRISPR-Cas, bacteriophage, microbiome, and metabolic engineering-based… — Europe PMC PMID:41923586},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41923586},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7421decbe7bd; sha256 ffd01d83ebcbcb8afd2bbf8a88144c279ab39df6b5b407266ffdb5cbd85ff462},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41923586. Agents can read the archived copy with the MCP tool read_document.